BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4800661)

  • 1. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
    Matĕjková E; Vlastiborová A
    Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphological changes in the nucleoli of peripheral-blood lymphocytes as prognostic criteria in the chemotherapy of malignant tumors.
    Matĕjoková E; Smetana K
    Neoplasma; 1975; 22(3):303-12. PubMed ID: 1174261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of combined administration of cytembena and cyclophosphamide on the blood count and morphology of nucleoli in peripheral-blood lymphocytes in patients with malignant tumors.
    Matĕjková E
    Neoplasma; 1975; 22(1):45-54. PubMed ID: 1173938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoli of lymphocytes in the peripheral blood of patients with gastric cancer and gastric ulcer.
    Smetana K; Matĕjková E; Likovský Z; Hondlík J
    Neoplasma; 1980; 27(6):717-21. PubMed ID: 7254427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)].
    Matĕjková E; Rezábek K; Polák E
    Cesk Gastroenterol Vyz; 1974 Jul; 28(4):279-85. PubMed ID: 4603038
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nucleoli of circulating lymphocytes in adults (review and personal contribution)].
    Gentili M
    Policlinico Prat; 1970 Oct; 77(41):1307-19. PubMed ID: 4098561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some clinical data on the state of patients with inoperable cancer of the internal sex organs treated with cytembena and cyclophosphamide preparations].
    Novotna J; Jandova A; Laurova L; Skoda V
    Akush Ginekol (Mosk); 1973 Aug; 49(8):71. PubMed ID: 4800858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the nucleolar coefficient in lymphocytes in chemotherapeutically treated patients with ovarian carcinoma].
    Jandrová A; Laurová L; Skoda V; Trnka V
    Zentralbl Bakteriol Orig B; 1975; 91(9):549-51. PubMed ID: 1189808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid composition of erythrocyte membranes in patients with cancer].
    Novitskiĭ VV; Stepovaia EA; Bazhenova NG; Gol'dberg VE; Kolosova MV; Saprykina EV; Gubert EA; Sokolova IB; Koreshkova KG; Bulavina IaV
    Biull Eksp Biol Med; 1998 Aug; 126(8):204-6. PubMed ID: 9777238
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of incorporation of labelled cyclophosphamide cytembena into human tumour.
    Jandová A; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4765907
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of incorporation of labelled cyclophosphamide and cytembena into human tumour.
    Jandov A ; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4725516
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of platelet aggregation in cancer patients].
    Shilova AN; Kotovshchikova EF; Lazarev AF; Barkagan ZS; Buevich EI
    Vopr Onkol; 2007; 53(6):722-3. PubMed ID: 18416146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peripheral circulating lymphocytes in patients with cancer].
    Shirakami A; Iwao N; Imagawa T; Hashizume H; Kohama T
    Saishin Igaku; 1969 Aug; 24(8):1664-71. PubMed ID: 4902061
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs.
    Kopeć J; Sitarska E; Leszko B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II clinical trial of cytembena. Clinical screening group of E.O.R.T.C.
    Biomedicine; 1977 Dec; 26(6):392-5. PubMed ID: 342004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results obtained with chemotherapy of ovarian cancer respecting its morphological structure (author's transl)].
    Skoda V; Cizková J; Hrádek D; Jandová A; Janousková M; Laurová L
    Cesk Gynekol; 1976 Dec; 41(10):716-17. PubMed ID: 1036972
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of thrombocytopoiesis in patients with cancer of the digestive tract].
    Anikin BS
    Vrach Delo; 1967 Jun; 6():18-20. PubMed ID: 5614034
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of Cytembena in man.
    Grafnetterová J; Schück O; Smahel O; König J; Růzicková S
    Neoplasma; 1971; 18(5):447-54. PubMed ID: 5119517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.